JP2013511496A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013511496A5 JP2013511496A5 JP2012539355A JP2012539355A JP2013511496A5 JP 2013511496 A5 JP2013511496 A5 JP 2013511496A5 JP 2012539355 A JP2012539355 A JP 2012539355A JP 2012539355 A JP2012539355 A JP 2012539355A JP 2013511496 A5 JP2013511496 A5 JP 2013511496A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- carbon atoms
- dosage form
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 12
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 239000002552 dosage form Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 150000002430 hydrocarbons Chemical group 0.000 claims 3
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 claims 3
- 229960004134 propofol Drugs 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 206010002091 Anaesthesia Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 206010039897 Sedation Diseases 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000037005 anaesthesia Effects 0.000 claims 1
- 208000029028 brain injury Diseases 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 239000007922 nasal spray Substances 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- 230000004112 neuroprotection Effects 0.000 claims 1
- 239000000668 oral spray Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 230000036280 sedation Effects 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09014548.3 | 2009-11-23 | ||
| EP09014548A EP2332525A1 (en) | 2009-11-23 | 2009-11-23 | Pharmaceutical composition comprising propofol |
| PCT/EP2010/067938 WO2011061332A1 (en) | 2009-11-23 | 2010-11-22 | Pharmaceutical composition comprising propofol |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013511496A JP2013511496A (ja) | 2013-04-04 |
| JP2013511496A5 true JP2013511496A5 (OSRAM) | 2013-12-05 |
| JP5707009B2 JP5707009B2 (ja) | 2015-04-22 |
Family
ID=41694756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012539355A Active JP5707009B2 (ja) | 2009-11-23 | 2010-11-22 | プロポフォールを含有する医薬組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8796340B2 (OSRAM) |
| EP (2) | EP2332525A1 (OSRAM) |
| JP (1) | JP5707009B2 (OSRAM) |
| KR (1) | KR20120104262A (OSRAM) |
| CN (1) | CN102753159B (OSRAM) |
| AU (1) | AU2010320823B2 (OSRAM) |
| BR (1) | BR112012012108A2 (OSRAM) |
| CA (1) | CA2776855C (OSRAM) |
| ES (1) | ES2450423T3 (OSRAM) |
| IN (1) | IN2012DN03130A (OSRAM) |
| MX (1) | MX2012005881A (OSRAM) |
| WO (1) | WO2011061332A1 (OSRAM) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10045996B2 (en) | 2010-03-17 | 2018-08-14 | Novaliq Gmbh | Pharmaceutical composition for treatment of increased intraocular pressure |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| ES2962524T3 (es) | 2011-05-25 | 2024-03-19 | Dermaliq Therapeutics Inc | Composición farmacéutica tópica a base de alcanos semifluorados |
| AU2012260788B2 (en) | 2011-05-25 | 2017-01-19 | Dermaliq Therapeutics, Inc. | Pharmaceutical composition for administration to nails |
| GB201116271D0 (en) | 2011-09-21 | 2011-11-02 | Univ Cardiff | Dispersion anaesthetic device |
| PL2806886T3 (pl) | 2012-01-23 | 2017-08-31 | Novaliq Gmbh | Stabilizowane kompozycje białkowe oparte na semifluorowanych alkanach |
| DK2708228T3 (en) * | 2012-09-12 | 2018-08-20 | Novaliq Gmbh | COMPOSITION FOR EYE RINSE |
| PL2895144T3 (pl) | 2012-09-12 | 2017-07-31 | Novaliq Gmbh | Kompozycje semifluorowanych alkanów |
| CN113952321B (zh) | 2012-09-12 | 2023-03-28 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| US10273298B2 (en) | 2013-07-23 | 2019-04-30 | Novaliq Gmbh | Stabilized antibody compositions |
| EP2944324A1 (de) * | 2014-05-13 | 2015-11-18 | LTS LOHMANN Therapie-Systeme AG | Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen |
| JP2017531011A (ja) | 2014-10-16 | 2017-10-19 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 麻酔のための新規の方法、化合物および組成物 |
| CN110403923B (zh) | 2015-09-30 | 2021-09-21 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
| JP6642935B2 (ja) | 2015-09-30 | 2020-02-12 | ノバリック ゲーエムベーハー | 眼投与用の半フッ素化化合物 |
| CN109640900B (zh) | 2016-06-23 | 2020-07-07 | 诺瓦利克有限责任公司 | 一种试剂盒 |
| CN116172987A (zh) | 2016-09-22 | 2023-05-30 | 诺瓦利克有限责任公司 | 用于治疗睑缘炎的药物组合物 |
| US10813976B2 (en) | 2016-09-23 | 2020-10-27 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
| JP7032404B2 (ja) | 2016-12-23 | 2022-03-08 | ノバリック ゲーエムベーハー | ドライアイ疾患の治療のための眼科用組成物 |
| WO2018193093A1 (en) | 2017-04-21 | 2018-10-25 | Novaliq Gmbh | Iodine compositions |
| CN110650734B (zh) | 2017-05-12 | 2024-11-15 | 诺瓦利克有限责任公司 | 治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物 |
| BR112020006072A2 (pt) | 2017-09-27 | 2020-10-06 | Novaliq Gmbh | composições oftalmáticas compreendendo latanoprost para uso no tratamento de doenças oculares |
| US11896559B2 (en) | 2017-10-04 | 2024-02-13 | Novaliq Gmbh | Opthalmic compositions comprising F6H8 |
| US11576893B2 (en) | 2018-03-02 | 2023-02-14 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
| JP2021522219A (ja) | 2018-04-27 | 2021-08-30 | ノバリック ゲーエムベーハー | 緑内障の治療のためのタフルプロストを含む眼科用組成物 |
| JP7360452B2 (ja) | 2018-09-27 | 2023-10-12 | ダーマリック セラピューティクス， インコーポレーテッド | 脂質バリアの修復 |
| CA3112031A1 (en) | 2018-10-12 | 2020-04-16 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| US12397039B2 (en) | 2019-02-13 | 2025-08-26 | Novaliq Gmbh | Compositions and methods for the treatment of ocular neovascularization |
| KR20220058577A (ko) | 2019-09-06 | 2022-05-09 | 노바리크 게엠베하 | 포도막염 치료를 위한 안과용 조성물 |
| EP3912622A1 (en) | 2020-05-19 | 2021-11-24 | tesa Labtec GmbH | Oral film for safe administration of api |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496537A (en) * | 1995-03-23 | 1996-03-05 | Henry; Richard A. | Propofol hydrofluorocarbon propellant formulations |
| DE19536504C2 (de) | 1995-09-29 | 1999-09-23 | H Meinert | Verwendung fluorierter Alkane |
| EP1124416A1 (en) * | 1999-03-15 | 2001-08-22 | John Claude Krusz | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages |
| GB0124071D0 (en) * | 2001-10-08 | 2001-11-28 | Kbig Ltd | Improvement in the administration of high boiling point aneasthetics |
| JP2007519634A (ja) * | 2004-01-02 | 2007-07-19 | ウィスコンシン・アルムニ・リサーチ・ファウンデーション | 半フッ素化ブロック共重合体またはフッ素化ブロック共重合体から形成されるフルオラスコアおよびフルオラス内側シェルのミセルにおける化学物質のカプセル化 |
| DE102004030044A1 (de) | 2004-06-22 | 2006-01-12 | Birken Gmbh | Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels |
| US9000048B2 (en) * | 2006-11-28 | 2015-04-07 | Wisconsin Alumni Research Foundation | Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics |
| PT2110126E (pt) | 2008-04-18 | 2012-02-20 | Novaliq Gmbh | Utilização inalativa e instilativa de alcanos semifluorados como veículos de substância activa na região intrapulmonar |
-
2009
- 2009-11-23 EP EP09014548A patent/EP2332525A1/en not_active Withdrawn
-
2010
- 2010-11-22 BR BR112012012108A patent/BR112012012108A2/pt not_active Application Discontinuation
- 2010-11-22 US US13/511,184 patent/US8796340B2/en active Active
- 2010-11-22 JP JP2012539355A patent/JP5707009B2/ja active Active
- 2010-11-22 CA CA2776855A patent/CA2776855C/en active Active
- 2010-11-22 AU AU2010320823A patent/AU2010320823B2/en active Active
- 2010-11-22 EP EP10778677.4A patent/EP2503999B1/en active Active
- 2010-11-22 MX MX2012005881A patent/MX2012005881A/es not_active Application Discontinuation
- 2010-11-22 ES ES10778677.4T patent/ES2450423T3/es active Active
- 2010-11-22 CN CN201080052400.7A patent/CN102753159B/zh active Active
- 2010-11-22 IN IN3130DEN2012 patent/IN2012DN03130A/en unknown
- 2010-11-22 KR KR1020127016348A patent/KR20120104262A/ko not_active Withdrawn
- 2010-11-22 WO PCT/EP2010/067938 patent/WO2011061332A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013511496A5 (OSRAM) | ||
| US10639439B2 (en) | Smokeless THC and administration method thereof | |
| ES2894836T3 (es) | Compuestos de CBD fluorados, composiciones y usos de los mismos | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2013542247A5 (OSRAM) | ||
| JP2014506583A5 (OSRAM) | ||
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| JP2011500781A5 (OSRAM) | ||
| JP2012530779A5 (OSRAM) | ||
| JP2015529229A5 (OSRAM) | ||
| EA201500293A1 (ru) | Антихолинэргическая нейропротективная композиция и способы | |
| RU2018135967A (ru) | Интраназальные фармацевтические композиции на основе бензодиазепина | |
| PE20091672A1 (es) | Nueva dosificacion y formulacion | |
| RU2015136849A (ru) | Композиции, содержащие 15-он эпк, и способы их применения | |
| EA201401354A1 (ru) | Новая дозированная форма и препарат, содержащий абедитерол | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| JP2014515407A5 (OSRAM) | ||
| JP2015509075A5 (OSRAM) | ||
| AR087868A1 (es) | Compuestos de triazolopiridina como moduladores de la tirosina quinasa c-met | |
| MX2012005689A (es) | Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos. | |
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| RU2008124825A (ru) | Органические соединения, включающие соль гликопиррония | |
| JP2015502371A5 (OSRAM) | ||
| EP2476429A4 (en) | PTH-CONTAINING THERAPY / PROPHYLAXIS AGENT FOR OSTEOPOROSIS ONCE PER WEEK, WITH ONE UNIT DOSE OF 100 TO 200 UNITS OF SUCCESSFUL PTH ADMINISTRATION | |
| JP2014511897A5 (OSRAM) |